Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2002-12-26
2009-12-01
Epps-Smith, Janet L. (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C435S006120, C435S325000, C435S375000, C514S04400A, C536S023100, C536S024300, C536S024500
Reexamination Certificate
active
07625750
ABSTRACT:
DNA compositions that mediate gene silencing via RNA interference are provided. The DNA compositions include an RNA polymerase III promoter, which drives expression of a nucleotide sequence encoding an intermediate small interfering RNA molecule, and RNA polymerase III terminator.
REFERENCES:
patent: 5624803 (1997-04-01), Noonberg et al.
patent: 6423885 (2002-07-01), Waterhouse et al.
patent: 6506559 (2003-01-01), Fire et al.
patent: 2002/0006664 (2002-01-01), Sabatini
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2003/0027168 (2003-02-01), Gan et al.
patent: WO96/26963 (1996-09-01), None
patent: WO99/32619 (1999-07-01), None
patent: WO 99/53050 (1999-10-01), None
patent: WO 01/12824 (2001-02-01), None
patent: WO01/29058 (2001-04-01), None
patent: WO01/68836 (2001-09-01), None
patent: WO01/75164 (2001-10-01), None
patent: WO01/92513 (2001-12-01), None
patent: WO01/96584 (2001-12-01), None
patent: WO02/44321 (2002-06-01), None
patent: WO 02/059257 (2002-08-01), None
patent: WO 02/059294 (2002-08-01), None
patent: WO 03/046186 (2003-06-01), None
patent: WO 03070877 (2003-08-01), None
Ilves et al. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study. Gene. 1996. vol. 171, pp. 203-208.
Kunkel et al., Genes & Development. Feb. 1988, vol. 2(2), pp. 196-204.
Good et al. Gene Therapy. 1997, vol. 4, pp. 45-54.
Lee et al., “Expression of small interfering RNAs targeted against HIV-1revtranscripts in human cells,”Nature Biology, vol. 19, May 2002, pp. 500-505.
Yu et al., “RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells,”PNAS, vol. 99, No. 9, Apr. 30, 2002, pp. 6047-6052.
Sui et al., “A DNA vector-based RNAi technology to suppress gene expression in mammalian cells,”PNAS, vol. 99, No. 8, Apr. 16, 2002, pp. 5515-5520.
Brummelkamp et al., “A System for Stable Expression of Short Interfering RNAs in Mammalian Cells,”Science, vol. 296, Apr. 19, 2002, pp. 550-553.
Paddison et al., “Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells,”Genes&Development, vol. 16, Mar. 8, 2002, pp. 948-958.
Caplen et al., “Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems,”PNAS, vol. 98, Aug. 14, 2001, pp. 9742-9747.
Elbashir et al., “Duplexes of 21—nucleotide RNAs mediate RNA interference in cultured mammalian cells,”Nature, vol. 411, May 24, 2001, pp. 494-498.
Parrish et al., “Functional Anatomy of a dsRNA Trigger: Differential Requirement for the Two Trigger Strands in RNA Interference,”Molecular Cell, vol. 6, Nov. 2000, pp. 1077-1087.
Kennerdell and Carthew, “Use of dsRNA-Mediated Genetic Interference to Demonstrate thatfrizzledandfrizzled2 Act in the Wingless Pathway,”Cell, vol. 95, Dec. 23, 1998, pp. 1017-1026.
Fire et al., “Potent and specific genetic interference by double-stranded RNA inCaenorhabditis elegans,”Nature, vol. 391, Feb. 19, 1998, pp. 806-811.
Lin, S-L et al., “D-RNAi (Messenger RNA-antisense DNA Interference) as a Novel Defense System Against Cancer and Viral Infections”,Bentham Science, vol. 1, No. 3, pp. 241-247, 2001.
Miyagishi, M. et al, “U6 promoter-driven siRNAs with four uridine 3' overhangs efficiently suppress targeted gene expression in mammalian cells”,Nature Biotechnology, vol. 19, No. 5, pp. 497-500, 2002.
Sui, G. et al., “A DNA vector-based RNAi technology to suppress gene expression in mammalian cells”,PNAS, vol. 99, No. 8, pp. 5515-5520, 2002.
Stünkel et al., “A Nucleosome Positioned in the Distal Promoter Region Activates Transcription of the Human U6 Gene,”Molecular and Cellular Biology, 17:8, Aug. 1997, pp. 4397-4405.
Ziauddin and Sabatini, “Microarrays of cells expressing defined cDNAs,”Nature, vol. 411, May 3, 2001, pp. 107-110.
Allele Biotechnology & Pharmaceuticals, Inc.
DLA Piper (LLP) US
Epps-Smith Janet L.
LandOfFree
Compositions for DNA mediated gene silencing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for DNA mediated gene silencing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for DNA mediated gene silencing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4121607